Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) Invested Capital (2018 - 2025)

Historic Invested Capital for Bio (TELA) over the last 8 years, with Q3 2025 value amounting to $41.6 million.

  • Bio's Invested Capital rose 76257.97% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.6 million, marking a year-over-year increase of 76257.97%. This contributed to the annual value of $68.5 million for FY2024, which is 26257.61% up from last year.
  • Per Bio's latest filing, its Invested Capital stood at $41.6 million for Q3 2025, which was up 76257.97% from $12.5 million recorded in Q2 2025.
  • Bio's 5-year Invested Capital high stood at $72.7 million for Q1 2021, and its period low was -$6.3 million during Q3 2024.
  • Over the past 5 years, Bio's median Invested Capital value was $23.3 million (recorded in 2022), while the average stood at $30.1 million.
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 269435.8% in 2023, then tumbled by 12052.89% in 2024.
  • Over the past 5 years, Bio's Invested Capital (Quarter) stood at $51.6 million in 2021, then plummeted by 72.27% to $14.3 million in 2022, then soared by 31.99% to $18.9 million in 2023, then soared by 262.58% to $68.5 million in 2024, then tumbled by 39.3% to $41.6 million in 2025.
  • Its last three reported values are $41.6 million in Q3 2025, $12.5 million for Q2 2025, and $18.1 million during Q1 2025.